Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Mucha
Bortezomib-Based Regimens Used as Induction in Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible for Stem Cell Transplantation (Sct)The Cost-Utility Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
Stem Cells International
Cell Biology
Molecular Biology
Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma
Haematologica
Hematology
Psy17 - Treatment Regimens for Patients With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation: A Systematic Literature Review and Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-Life Autologous Stem Cell Transplantation and Overall Survival Rates in Newly Diagnosed Multiple Myeloma Patients: An Analysis Based on a German Claims Dataset
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Bortezomib Plus Dexamethasone Induction Followed by Autologous Stem Cell Transplantation in Multiple Myeloma: A Study From India
Asian Journal of Medical Sciences
Pcn332 - Real-World Usage of Bortezomib in Combination With Thalidomide and Dexamethasone (Vtd) as Frontline (Fl) Treatment in Stem Cell Transplant (Sct) Eligible Multiple Myeloma (Mm) Patients Across Eu5 Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Stem Cell Mobilization and Autograft Purity With Novel Induction Regimens in Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Cell Transplantation for Consolidation of VGPR or CR for Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
